Suppliers shipping without cold chain maintenance deliver products with unknown remaining activity
Cyanokit received a priority review and was approved under the Animal Efficacy Rule, which allows use of animal data for evidence of a drug's effectiveness for certain conditions when the drug cannot be ethically or feasibly tested in humans
Muc1: A multifaceted oncoprotein with a key role in cancer progression
PMID 40461817
Side Effects : In addition to the shared GLP-1 side effects above, injection reactions are other potential side effects
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells